Certara, Inc. (NASDAQ:CERT) Receives Consensus Rating of “Hold” from Brokerages

Certara, Inc. (NASDAQ:CERT) has been assigned a consensus rating of “Hold” from the eleven research firms that are currently covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $20.06.

CERT has been the subject of several research analyst reports. JMP Securities initiated coverage on Certara in a report on Thursday, April 4th. They issued a “market perform” rating for the company. Jefferies Financial Group increased their price objective on Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a report on Friday, March 1st. UBS Group increased their price objective on Certara from $17.00 to $20.00 and gave the stock a “neutral” rating in a report on Friday, March 1st. KeyCorp upgraded Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 price objective for the company in a report on Wednesday, April 10th. Finally, Leerink Partnrs reiterated a “market perform” rating on shares of Certara in a report on Monday, February 26th.

Certara Price Performance

CERT opened at $16.73 on Monday. The stock’s 50 day simple moving average is $17.19 and its 200 day simple moving average is $16.80. The company has a debt-to-equity ratio of 0.27, a current ratio of 3.26 and a quick ratio of 3.26. Certara has a 1 year low of $11.81 and a 1 year high of $22.65. The firm has a market cap of $2.69 billion, a price-to-earnings ratio of -42.90, a PEG ratio of 5.66 and a beta of 1.61.

Certara (NASDAQ:CERT) last posted its quarterly earnings results on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.01). Certara had a positive return on equity of 4.08% and a negative net margin of 17.02%. The company had revenue of $96.65 million for the quarter, compared to the consensus estimate of $94.48 million. As a group, analysts predict that Certara will post 0.29 earnings per share for the current year.

Insider Activity

In other news, SVP Richard M. Traynor sold 3,000 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $18.00, for a total value of $54,000.00. Following the completion of the transaction, the senior vice president now owns 173,524 shares in the company, valued at approximately $3,123,432. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Certara news, SVP Richard M. Traynor sold 3,000 shares of Certara stock in a transaction on Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the transaction, the senior vice president now owns 173,524 shares in the company, valued at $3,123,432. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Patrick F. Smith sold 14,427 shares of Certara stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total value of $243,094.95. Following the transaction, the insider now owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The disclosure for this sale can be found here. 2.39% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in CERT. Mubadala Investment Co PJSC purchased a new position in Certara during the fourth quarter valued at $169,135,000. Wasatch Advisors LP raised its stake in Certara by 23.4% during the first quarter. Wasatch Advisors LP now owns 4,924,845 shares of the company’s stock valued at $88,056,000 after buying an additional 932,598 shares during the last quarter. Geneva Capital Management LLC raised its stake in Certara by 29.0% during the fourth quarter. Geneva Capital Management LLC now owns 3,824,850 shares of the company’s stock valued at $67,279,000 after buying an additional 860,763 shares during the last quarter. Norges Bank purchased a new position in Certara during the fourth quarter valued at $14,262,000. Finally, Rathbones Group PLC bought a new stake in shares of Certara in the 3rd quarter worth $11,007,000. Hedge funds and other institutional investors own 73.96% of the company’s stock.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.